Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Barbara E. Stähli, Roland Klingenberg, Dik Heg, Mattia Branca, Robert Manka, Ioannis Kapos, Oliver Müggler, Andrea Denegri, Rahel Kesterke, Florence Berger, Julia Stehli, Alessandro Candreva, Arnold von Eckardstein, David Carballo, Christian Hamm, Ulf Landmesser, François Mach, Tiziano Moccetti, Christian Jung, Malte Kelm, Thomas Münzel, Giovanni Pedrazzini, Lorenz Räber, Stephan Windecker, Christian Templin, Christian M. Matter, Thomas F. Lüscher, Frank Ruschitzka
Institutions: University of Zurich, University Hospital Zurich, Justus-Liebig-Universität Gießen, German Centre for Cardiovascular Research, Kerckhoff Klinik, University of Bern, University Hospital of Geneva, Stiftung Charité, Charité - Universitätsmedizin Berlin, Düsseldorf University Hospital, University Medical Center of the Johannes Gutenberg University Mainz, University Hospital of Bern, Harefield Hospital, Royal Brompton Hospital, Imperial College London
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: National Science Foundation, Amgen, Pfizer, AstraZeneca, Sanofi, Edwards Lifesciences, Boston Scientific Corporation, Regeneron Pharmaceuticals, B. Braun-Stiftung, Deutsches Zentrum für Herz-Kreislaufforschung, Abiomed, Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Deutsche Stiftung für Herzforschung, Universität Zürich, Servier, Abbott Vascular
OpenAlex ID: W4293451387